DrugDashboards

Xylocaine

Lidocaine Hydrochloride,epinephrine Bitartrate · LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE .01 mg/mL · Injection, Solution · Infiltration; Perineural · Sportpharm LLC

NDC 85766-0190-25 · 25 VIAL, MULTI-DOSE in 1 TRAY / 20 mL in 1 VIAL, MULTI-DOSE · NDA · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “demand increase for the drug”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $10.16 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA006488
TE code
AP
Approval date
Jan 1, 1982
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17)Oct 14, 2016
    Demand increase for the drug
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37)Oct 14, 2016
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17)Oct 14, 2016
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27)Oct 14, 2016
    Other
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)Oct 14, 2016
    Demand increase for the drug
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17)Oct 14, 2016
    Demand increase for the drug
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27)Oct 14, 2016
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57)Oct 14, 2016
    Other
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27)Oct 14, 2016
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57)Oct 14, 2016
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Lidocaine Hydrochloride,epinephrine Bitartrate (Injection, Solution)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsLIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mL; EPINEPHRINE BITARTRATE .01 mg/mLAug 26, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 15 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mLAug 26, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 5 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mLAug 26, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mL; EPINEPHRINE BITARTRATE .01 mg/mLAug 26, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mLAug 26, 2026Sep 2, 2026
ProPharma DistributionLIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE .01 mg/mLAug 26, 2026Sep 2, 2026
Remedyrepack Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE .01 mg/mLAug 26, 2026Sep 2, 2026
Sportpharm LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE .01 mg/mLAug 26, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE .01 mg/mLAug 26, 2026Aug 31, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS .01 mg/mL; EPINEPHRINE BITARTRATE 10 mg/mLJul 22, 2026Aug 21, 2026
A-S Medication SolutionsLIDOCAINE HYDROCHLORIDE ANHYDROUS .01 mg/mL; EPINEPHRINE BITARTRATE 20 mg/mLJul 22, 2026Aug 19, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS .005 mg/mL; EPINEPHRINE BITARTRATE 5 mg/mLJul 22, 2026Aug 19, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS .005 mg/mL; EPINEPHRINE BITARTRATE 20 mg/mLJul 22, 2026Aug 19, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS .005 mg/mL; EPINEPHRINE BITARTRATE 15 mg/mLJul 22, 2026Aug 19, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS .01 mg/mL; EPINEPHRINE BITARTRATE 20 mg/mLJul 22, 2026Aug 19, 2026
ProPharma DistributionLIDOCAINE HYDROCHLORIDE ANHYDROUS .01 mg/mL; EPINEPHRINE BITARTRATE 10 mg/mLJul 22, 2026Aug 19, 2026
Remedyrepack Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS .01 mg/mL; EPINEPHRINE BITARTRATE 10 mg/mLJul 22, 2026Aug 19, 2026
Sportpharm LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS .01 mg/mL; EPINEPHRINE BITARTRATE 10 mg/mLJul 22, 2026Aug 19, 2026
Fresenius Kabi USA, LLCEPINEPHRINE BITARTRATE .01 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mLJul 15, 2026Jul 18, 2026
A-S Medication SolutionsEPINEPHRINE BITARTRATE .01 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Jul 15, 2026
Fresenius Kabi USA, LLCEPINEPHRINE BITARTRATE .005 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 15 mg/mLJul 15, 2026Jul 15, 2026
Fresenius Kabi USA, LLCEPINEPHRINE BITARTRATE .01 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Jul 15, 2026
Fresenius Kabi USA, LLCEPINEPHRINE BITARTRATE .005 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 5 mg/mLJul 15, 2026Jul 15, 2026
Fresenius Kabi USA, LLCEPINEPHRINE BITARTRATE .005 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Jul 15, 2026
ProPharma DistributionEPINEPHRINE BITARTRATE .01 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mLJul 15, 2026Jul 15, 2026
Remedyrepack Inc.EPINEPHRINE BITARTRATE .01 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mLJul 15, 2026Jul 15, 2026
Sportpharm LLCEPINEPHRINE BITARTRATE .01 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Xylocaine — NDC 85766-0190-25," retrieved September 3, 2026, https://drugdashboards.com/drug/85766019025.

Free to cite with attribution — see how the data is put together.